Clinical Trial Update: Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating propranolol for pediatric recurrent respiratory papillomatosis has been withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Recurrent Respiratory Papillomatosis | Phase 2, Phase 3 | Status: WITHDRAWN